NCT03360461View on ClinicalTrials.gov

EMI-137 in Laparoscopic Colonic Resections

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

February 14, 2018

Primary Completion Date

February 14, 2020

Study Completion Date

March 14, 2020

Conditions
Colonic CancerMetastasis to Lymph Node
Interventions
DRUG

EMI-137

EMI-137 - a fluorescent c-Met receptor targeted peptide

Trial Locations (1)

LS8 1RN

St James' University Hospital Trust, Leeds

Sponsors
All Listed Sponsors
collaborator

Edinburgh Molecular Imaging Ltd

UNKNOWN

lead

University of Leeds

OTHER